{"title":"对视神经的贡献","authors":"Marija Radenković","doi":"10.5772/INTECHOPEN.80278","DOIUrl":null,"url":null,"abstract":"Optic nerve head drusen (ONHD) represent congenital anomaly, which is a form of calcium degeneration of optic nerve head axons. They are initially asymptomatic but may causes progressive optic neuropathy. They are presented as acellular, hyaline deposits of globular appearance in front of the lamina cribrosa (prelaminar segment). They are formed due to altered axonal transport, small diameter of scleral canal, direct compression, or ischemia. Frequent complications: progressive visual field scotoma, ischemic optic neuropathy, central retinal artery or vein occlusion, and neovascularization adjacent to the optic nerve head. Useful diagnostic tools ophthalmoscopy, angiography, standard automated perimetry, B-scan ultrasonography, CT, OCT, HRT, GDx, and electrophysiological examination. Therapeutic procedures are medical, laser, and surgical. Pilot studies confirmed benefit of topical hypotensive drugs even when drusen are not associated with glaucoma. By reducing intraocular pressure, the compression to the optic nerve axons decreases, thus improving perfusion of the optic nerve head. The paper presents young female patient with bilateral optic nerve drusen and progressive visual field defects (scotomas), which implies topical hypotensive therapy. After 6 months scotoma and loss of sensitivity of the visual field were reduced. Neuroprotective drugs are investigated to reduce potential visual morbidity.","PeriodicalId":196485,"journal":{"name":"Optic Nerve","volume":"20 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Contribution to the Optic Nerve\",\"authors\":\"Marija Radenković\",\"doi\":\"10.5772/INTECHOPEN.80278\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Optic nerve head drusen (ONHD) represent congenital anomaly, which is a form of calcium degeneration of optic nerve head axons. They are initially asymptomatic but may causes progressive optic neuropathy. They are presented as acellular, hyaline deposits of globular appearance in front of the lamina cribrosa (prelaminar segment). They are formed due to altered axonal transport, small diameter of scleral canal, direct compression, or ischemia. Frequent complications: progressive visual field scotoma, ischemic optic neuropathy, central retinal artery or vein occlusion, and neovascularization adjacent to the optic nerve head. Useful diagnostic tools ophthalmoscopy, angiography, standard automated perimetry, B-scan ultrasonography, CT, OCT, HRT, GDx, and electrophysiological examination. Therapeutic procedures are medical, laser, and surgical. Pilot studies confirmed benefit of topical hypotensive drugs even when drusen are not associated with glaucoma. By reducing intraocular pressure, the compression to the optic nerve axons decreases, thus improving perfusion of the optic nerve head. The paper presents young female patient with bilateral optic nerve drusen and progressive visual field defects (scotomas), which implies topical hypotensive therapy. After 6 months scotoma and loss of sensitivity of the visual field were reduced. Neuroprotective drugs are investigated to reduce potential visual morbidity.\",\"PeriodicalId\":196485,\"journal\":{\"name\":\"Optic Nerve\",\"volume\":\"20 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-11-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Optic Nerve\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5772/INTECHOPEN.80278\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Optic Nerve","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/INTECHOPEN.80278","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Optic nerve head drusen (ONHD) represent congenital anomaly, which is a form of calcium degeneration of optic nerve head axons. They are initially asymptomatic but may causes progressive optic neuropathy. They are presented as acellular, hyaline deposits of globular appearance in front of the lamina cribrosa (prelaminar segment). They are formed due to altered axonal transport, small diameter of scleral canal, direct compression, or ischemia. Frequent complications: progressive visual field scotoma, ischemic optic neuropathy, central retinal artery or vein occlusion, and neovascularization adjacent to the optic nerve head. Useful diagnostic tools ophthalmoscopy, angiography, standard automated perimetry, B-scan ultrasonography, CT, OCT, HRT, GDx, and electrophysiological examination. Therapeutic procedures are medical, laser, and surgical. Pilot studies confirmed benefit of topical hypotensive drugs even when drusen are not associated with glaucoma. By reducing intraocular pressure, the compression to the optic nerve axons decreases, thus improving perfusion of the optic nerve head. The paper presents young female patient with bilateral optic nerve drusen and progressive visual field defects (scotomas), which implies topical hypotensive therapy. After 6 months scotoma and loss of sensitivity of the visual field were reduced. Neuroprotective drugs are investigated to reduce potential visual morbidity.